Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Mirum Pharmaceuticals, Inc. | Director | Common Stock | 3.57M | $133M | $37.40 | Sep 18, 2024 | By Frazier Life Sciences IX, L.P. |
Imago BioSciences, Inc. | Director | Common Stock | 2.31M | $83.2M | $36.00 | Jul 20, 2021 | Indirect |
Mirum Pharmaceuticals, Inc. | Director | Common Stock | 162K | $6.07M | $37.40 | Sep 18, 2024 | By Frazier Life Sciences X, L.P. |
Arcutis Biotherapeutics, Inc. | Director, 10%+ Owner | Common Stock | 18.8K | $151K | $8.01 | Jun 14, 2024 | Direct |
Mirum Pharmaceuticals, Inc. | Director | Restricted Stock Units | 5.7K | $146K | $25.68 | Jun 5, 2024 | Direct |
MBX Biosciences, Inc. | Director, 10%+ Owner | Common Stock | 4.55M | Sep 16, 2024 | By Frazier Life Sciences X, L.P. | ||
Arcutis Biotherapeutics, Inc. | Director, 10%+ Owner | Stock Option (right to buy) | 27.1K | Jun 14, 2024 | Direct | ||
Imago BioSciences, Inc. | Director | Stock Option (Right to Buy) | 23.8K | Jul 15, 2021 | Direct | ||
HilleVax, Inc. | Director, 10%+ Owner | Stock Option | 22.5K | Jun 7, 2023 | Direct | ||
MBX Biosciences, Inc. | Director, 10%+ Owner | Stock Option (Right to Buy) | 16K | Sep 12, 2024 | Direct | ||
Vaxcyte, Inc. | Director | Stock Option (right to buy) | 15K | Jun 2, 2021 | Direct | ||
Mirum Pharmaceuticals, Inc. | Director | Stock Option (right to buy) | 8.78K | Jun 5, 2024 | Direct | ||
Imago BioSciences, Inc. | Director | Series A Preferred Stock | 0 | Jul 20, 2021 | Indirect | ||
Imago BioSciences, Inc. | Director | Series B Preferred Stock | 0 | Jul 20, 2021 | Indirect | ||
Imago BioSciences, Inc. | Director | Series C Preferred Stock | 0 | Jul 20, 2021 | Indirect | ||
MBX Biosciences, Inc. | Director, 10%+ Owner | Series A Convertible Preferred Stock | 0 | Sep 16, 2024 | By Frazier Life Sciences X, L.P. | ||
MBX Biosciences, Inc. | Director, 10%+ Owner | Series B Convertible Preferred Stock | 0 | Sep 16, 2024 | By Frazier Life Sciences X, L.P. |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
MIRM | Mirum Pharmaceuticals, Inc. | Sep 18, 2024 | 1 | $4.3K | 4 | Sep 20, 2024 | Director |
MBX | MBX Biosciences, Inc. | Sep 16, 2024 | 4 | $10M | 4 | Sep 17, 2024 | Director, 10%+ Owner |
MBX | MBX Biosciences, Inc. | Sep 12, 2024 | 1 | $0 | 4 | Sep 13, 2024 | Director, 10%+ Owner |
MBX | MBX Biosciences, Inc. | Sep 12, 2024 | 0 | $0 | 3 | Sep 12, 2024 | Director, 10%+ Owner |
MIRM | Mirum Pharmaceuticals, Inc. | Sep 6, 2024 | 1 | $9.56K | 4 | Sep 10, 2024 | Director |
ARQT | Arcutis Biotherapeutics, Inc. | Jun 14, 2024 | 2 | $0 | 4 | Jun 18, 2024 | Director, 10%+ Owner |
MIRM | Mirum Pharmaceuticals, Inc. | Jun 5, 2024 | 2 | $0 | 4 | Jun 7, 2024 | Director |
ARQT | Arcutis Biotherapeutics, Inc. | Mar 4, 2024 | 1 | $200K | 4 | Mar 6, 2024 | Director |
MIRM | Mirum Pharmaceuticals, Inc. | Nov 9, 2023 | 1 | $82.4K | 4 | Nov 14, 2023 | Director |
MIRM | Mirum Pharmaceuticals, Inc. | Sep 13, 2023 | 1 | $81.4K | 4 | Sep 15, 2023 | Director |
MIRM | Mirum Pharmaceuticals, Inc. | Sep 11, 2023 | 2 | $257K | 4 | Sep 13, 2023 | Director |
MIRM | Mirum Pharmaceuticals, Inc. | Aug 31, 2023 | 1 | $3.88M | 4 | Sep 5, 2023 | Director, 10%+ Owner |
MIRM | Mirum Pharmaceuticals, Inc. | Jun 12, 2023 | 1 | $0 | 4 | Jun 14, 2023 | Director, 10%+ Owner |
HLVX | HilleVax, Inc. | Jun 7, 2023 | 1 | $0 | 4 | Jun 9, 2023 | Director, 10%+ Owner |
ARQT | Arcutis Biotherapeutics, Inc. | May 31, 2023 | 2 | $0 | 4 | Jun 2, 2023 | Director, 10%+ Owner |
HLVX | HilleVax, Inc. | Aug 19, 2022 | 1 | $0 | 4 | Aug 23, 2022 | Director, 10%+ Owner |
MIRM | Mirum Pharmaceuticals, Inc. | Jun 2, 2022 | 1 | $0 | 4 | Jun 6, 2022 | Director, 10%+ Owner |
ARQT | Arcutis Biotherapeutics, Inc. | Jun 1, 2022 | 2 | $0 | 4 | Jun 3, 2022 | Director, 10%+ Owner |
IMGO | Imago BioSciences, Inc. | Jul 20, 2021 | 14 | $3M | 4 | Jul 20, 2021 | Director |
IMGO | Imago BioSciences, Inc. | Jul 15, 2021 | 1 | $0 | 4 | Jul 19, 2021 | Director |
IMGO | Imago BioSciences, Inc. | Jul 15, 2021 | 0 | $0 | 3 | Jul 15, 2021 | Director |
ARQT | Arcutis Biotherapeutics, Inc. | Jun 9, 2021 | 1 | $0 | 4 | Jun 11, 2021 | Director, 10%+ Owner |
MIRM | Mirum Pharmaceuticals, Inc. | Jun 4, 2021 | 1 | $0 | 4 | Jun 8, 2021 | Director, 10%+ Owner |
PCVX | Vaxcyte, Inc. | Jun 2, 2021 | 1 | $0 | 4 | Jun 3, 2021 | Director |